News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
765,101 Results
Type
Article (51088)
Company Profile (394)
Press Release (713619)
Section
Business (224713)
Career Advice (2527)
Deals (37985)
Drug Delivery (111)
Drug Development (86688)
Employer Resources (185)
FDA (17281)
Job Trends (16275)
News (377409)
Policy (36287)
Tag
Academia (2915)
Alliances (53428)
Alzheimer's disease (1355)
Approvals (17206)
Artificial intelligence (166)
Bankruptcy (377)
Best Places to Work (12489)
Biotechnology (276)
Breast cancer (199)
Cancer (1462)
Cardiovascular disease (126)
Career advice (2091)
CAR-T (107)
Cell therapy (318)
Clinical research (69019)
Collaboration (523)
Compensation (269)
COVID-19 (2740)
C-suite (121)
Data (1428)
Diabetes (190)
Diagnostics (6675)
Earnings (94488)
Employer resources (157)
Events (125475)
Executive appointments (413)
FDA (17981)
Funding (453)
Gene therapy (220)
GLP-1 (702)
Government (4996)
Healthcare (20678)
Infectious disease (2842)
Inflammatory bowel disease (126)
Interviews (424)
IPO (17363)
Job creations (4223)
Job search strategy (1789)
Layoffs (481)
Legal (8922)
Lung cancer (216)
Manufacturing (232)
Medical device (14330)
Medtech (14335)
Mergers & acquisitions (20778)
Metabolic disorders (518)
Neuroscience (1708)
NextGen Class of 2024 (7355)
Non-profit (5049)
Northern California (1738)
Obesity (300)
Opinion (232)
Patents (126)
People (61534)
Phase I (21484)
Phase II (30295)
Phase III (22691)
Pipeline (532)
Postmarket research (2817)
Preclinical (9309)
Radiopharmaceuticals (259)
Rare diseases (290)
Real estate (6627)
Regulatory (23941)
Research institute (2590)
Resumes & cover letters (431)
Southern California (1507)
Startups (3942)
United States (16023)
Vaccines (653)
Weight loss (230)
Date
Last 7 days (647)
Last 30 days (2454)
Last 365 days (37608)
2024 (37439)
2023 (42517)
2022 (53800)
2021 (58581)
2020 (57561)
2019 (51145)
2018 (38698)
2017 (35346)
2016 (35477)
2015 (41543)
2014 (35747)
2013 (30726)
2012 (32716)
2011 (33384)
2010 (31939)
Location
Africa (889)
Arizona (217)
Asia (44398)
Australia (7394)
California (3958)
Canada (1468)
China (319)
Colorado (180)
Connecticut (192)
Europe (99108)
Florida (549)
Georgia (145)
Illinois (438)
Indiana (239)
Maryland (675)
Massachusetts (3150)
Michigan (191)
Minnesota (312)
New Jersey (1148)
New York (1113)
North Carolina (851)
Northern California (1738)
Ohio (155)
Pennsylvania (944)
South America (1311)
Southern California (1507)
Texas (572)
Utah (115)
Washington State (418)
765,101 Results for "20 20 genesystems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Weight Loss
‘Bulls Disappointed’ as Amgen’s MariTide Demonstrates 20% Weight Loss
With Amgen’s MariTide results at the lower end of investors’ expectation of 20% to 25% weight loss, the much-anticipated readout sent the company’s shares tumbling.
November 26, 2024
·
2 min read
·
Annalee Armstrong
Multiple sclerosis
Study Casts Doubt on Benefit of Anti-CD20 Therapies in Multiple Sclerosis
New research has found that MS patients treated with anti-CD20 antibodies, such as Roche’s Ocrevus, do not experience significantly slower progression of disability.
September 26, 2024
·
2 min read
·
Tristan Manalac
BioForest
RareCyte secures $20M financing to expand the Orion™ Spatial Biology platform including Multiplex Assay Reagents, Software and Precision Biology Services
RareCyte, Inc. announced today the completion of a $20M financing from new and existing investors.
June 27, 2024
·
2 min read
Press Releases
Ocugen CEO to Present at NobleCon20 – Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference
November 27, 2024
·
3 min read
Press Releases
Tolerance Bio, Inc. Announces Scientific Advisory Board and Completion of $20.2 Million Seed Round to Advance Thymus-Based Therapies for Immune-Mediated Diseases
December 20, 2024
·
8 min read
Longeveron® to Present at the Virtual Life Sciences Investor Forum on June 20, 2024
Longeveron Inc. today announced that it will participate in the Virtual Life Sciences Investor Forum taking place June 20, 2024.
June 17, 2024
·
1 min read
Press Releases
Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference
November 26, 2024
·
5 min read
Deals
Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 20, 2024
Standard BioTools Inc. today announced that the Human Capital Committee of its Board of Directors, which is composed entirely of independent directors, granted an equity award effective as of May 20, 2024, under the Standard BioTools Inc. 2022 Inducement Equity Incentive Plan (Plan).
May 20, 2024
·
2 min read
Press Releases
Hidden Fat Predicts Alzheimer’s 20 Years Ahead of Symptoms
December 2, 2024
·
5 min read
BioCapital
Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common Stock
Incyte Corporation announced that its Board of Directors approved a share repurchase authorization of $2.0 billion.
May 13, 2024
·
9 min read
1 of 76,511
Next
